MENU
+Compare
OMGAQ
Stock ticker: OTC
AS OF
Jun 13 closing price
Price
$0.04
Change
+$0.01 (+33.33%)
Capitalization
2.05M

OMGAQ Omega Therapeutics, Inc. Forecast, Technical & Fundamental Analysis

Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers... Show more

OMGAQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for OMGAQ with price predictions
Jun 13, 2025

OMGAQ in +15.36% Uptrend, growing for three consecutive days on June 11, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where OMGAQ advanced for three days, in of 170 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 52 cases where OMGAQ's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 13, 2025. You may want to consider a long position or call options on OMGAQ as a result. In of 63 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for OMGAQ just turned positive on May 13, 2025. Looking at past instances where OMGAQ's MACD turned positive, the stock continued to rise in of 35 cases over the following month. The odds of a continued upward trend are .

OMGAQ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

OMGAQ moved below its 50-day moving average on May 19, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for OMGAQ crossed bearishly below the 50-day moving average on May 15, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The Aroon Indicator for OMGAQ entered a downward trend on May 20, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.177) is normal, around the industry mean (16.954). P/E Ratio (0.000) is within average values for comparable stocks, (59.376). OMGAQ's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.335). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.252) is also within normal values, averaging (257.043).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. OMGAQ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OMGAQ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
OMGAQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

OMGAQ is expected to report earnings to fall 13.33% to -25 cents per share on May 30

Omega Therapeutics, Inc. OMGAQ Stock Earnings Reports
Q1'25
Est.
$-0.26
Q4'24
Missed
by $0.07
The last earnings report on March 31 showed earnings per share of -30 cents, missing the estimate of -22 cents. With 411.20K shares outstanding, the current market capitalization sits at 2.05M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SUTNY5.340.01
+0.19%
Sumitomo Mitsui Trust Group, Inc.
TTISX12.57-0.09
-0.71%
Nuveen Quant Intl Sm Cap Eq Retirement
FOPPX58.64-0.71
-1.20%
Franklin Growth Opportunities R6
NILIF0.21-0.01
-2.70%
Surge Battery Metals Inc.
BTLCY5.19-0.17
-3.17%
British Land Company (The) PLC